Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Gilead Sciences 7.803, Baxter International 2.96.
Gilead Sciences vs Baxter International Net Worth and Market Cap
Gilead Sciences (GILD) and Baxter International (BAX) are peers in Healthcare. Gilead Sciences reported revenue of $7.8B as of Q2 2026, compared with $3.0B for Baxter International. Gilead Sciences leads on revenue.
Gilead Sciences's gross margin is 79.8% versus 34.9% for Baxter International. Gilead Sciences's net margin is -134.5% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Gilead Sciences, Baxter International.| Metric | Gilead Sciences | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $7.80B | $2.96B |
| Cost of Revenue | $1.58B | $1.93B |
| Gross Profit | $6.22B | $1.03B |
| Operating Income | $-10.39B | $217.00M |
| Net Income | $-10.50B | $126.00M |
| R&D Expense | $1.76B | $129.00M |
| Earnings Per Share | -$8.45 | $0.24 |
| Gross Margin | 79.8% | 34.9% |
| Operating Margin | -133.2% | 7.3% |
| Net Profit Margin | -134.5% | 4.3% |
| Free Cash Flow | $3.69B | $32.00M |
| Cumulative Free Cash Flow | $155.83B | $35.82B |
| Operating Cash Flow | $3.57B | $285.00M |
| Cash & Equivalents | $3.18B | $2.15B |